The federal Small Business Innovation Research (SBIR) program is a critical source of (non-dilutive!) funding for early stage companies, providing over $2 billion annually. New changes will increase the funding levels dedicated to the program and expand eligibility to small businesses that are majority-owned by multiple venture capital funds, hedge funds, or private equity firms. Hear from the Director of the National Cancer Institute’s (NCI) SBIR Development Center about new opportunities and about other initiatives, including the NCI SBIR Bridge Award ($3M awards in which NCI co-invests with private investors), and the NCI Investor Forum (connecting innovative SBIR awardees with top-tier investors and partners). More information and online registration is here.